{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T06:01:41Z","timestamp":1794204101544,"version":"4.8.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017050","name":"Cycle for Survival","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ygyno.2025.03.021","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T07:44:56Z","timestamp":1742370296000},"page":"144-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Anaplastic carcinoma of the ovary: A single-institution experience and molecular analysis"],"prefix":"10.1016","volume":"195","author":[{"given":"Mackenzie W.","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Herman","family":"Chui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier","family":"Selenica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Long Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel N.","family":"Grisham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrisann","family":"Kyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Momeni-Boroujeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Weigelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roisin E.","family":"O'Cearbhaill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2025.03.021_bb0005","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41379-020-0642-9","article-title":"Mural nodules in mucinous ovarian tumors represent a morphologic spectrum of clonal neoplasms: a morphologic, immunohistochemical, and molecular analysis of 13 cases","volume":"34","author":"Chapel","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2025.03.021_bb0010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/thy.2012.0252","article-title":"Sites of metastases of anaplastic thyroid carcinoma: autopsy findings in 45 cases from a single institution","volume":"23","author":"Besic","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.ygyno.2025.03.021_bb0015","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3332\/ecancer.2023.1557","article-title":"A mural nodule of anaplastic carcinoma with sarcomatoid differentiation in a background of ovarian borderline mucinous cystadenoma","volume":"17","author":"Uchime","year":"2023","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.ygyno.2025.03.021_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-241461","article-title":"Aggressive anaplastic ovarian carcinoma in a young nulliparous patient","volume":"14","author":"Hunter","year":"2021","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.ygyno.2025.03.021_bb0025","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211013159","article-title":"Anaplastic carcinoma showing rhabdoid features combined with ovarian mucinous borderline cystadenoma: a case report and literature review","volume":"49","author":"Sun","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ygyno.2025.03.021_bb0030","article-title":"Borderline ovarian mucinous tumor with anaplastic carcinomatous mural nodule: a case report","volume":"37","author":"Lakshmi Haridas","year":"2021","journal-title":"Gynecol. Oncol. Rep."},{"issue":"11","key":"10.1016\/j.ygyno.2025.03.021_bb0035","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/PAS.0000000000002294","article-title":"High-grade anaplastic transformation of ovarian serous borderline tumor: a distinctive morphology with abundant dense eosinophilic cytoplasm and dismal prognosis","volume":"48","author":"Zhang","year":"2024","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2025.03.021_bb0040","article-title":"Mucinous ovarian tumors with anaplastic mural nodules: case report","volume":"8","author":"Zou","year":"2021","journal-title":"Front. Med. (Lausanne)."},{"key":"10.1016\/j.ygyno.2025.03.021_bb0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13048-022-01010-3","article-title":"Ovarian mucinous borderline tumor with anaplastic carcinomatous nodules in adolescents","volume":"15","author":"Huang","year":"2022","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.ygyno.2025.03.021_bb0050","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.12998\/wjcc.v10.i21.7459","article-title":"Ovarian mucinous tumor with mural nodules of anaplastic carcinoma: three case reports","volume":"10","author":"Wang","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.ygyno.2025.03.021_bb0055","doi-asserted-by":"crossref","DOI":"10.1177\/20363613231172260","article-title":"Ovarian serous borderline tumor with mural nodules of anaplastic carcinoma and omental involvement: a case report","volume":"15","author":"Hernandez Acevedo","year":"2023","journal-title":"Rare Tumors"},{"key":"10.1016\/j.ygyno.2025.03.021_bb0060","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/1097-0142(197910)44:4<1327::AID-CNCR2820440425>3.0.CO;2-P","article-title":"Sarcomas in ovarian mucinous tumors: a report of two cases","volume":"44","author":"Prat","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2025.03.021_bb0065","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/1097-0142(197910)44:4<1332::AID-CNCR2820440426>3.0.CO;2-#","article-title":"Ovarian mucinous tumors with sarcoma-like mural nodules: a report of seven cases","volume":"44","author":"Prat","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2025.03.021_bb0070","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/1097-0142(19820715)50:2<300::AID-CNCR2820500222>3.0.CO;2-E","article-title":"Ovarian mucinous tumors with foci of anaplastic carcinoma","volume":"50","author":"Prat","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2025.03.021_bb0075","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1097\/00000478-200211000-00009","article-title":"Sarcoma-like mural nodules in mucinous cystic tumors of the ovary revisited: a clinicopathologic analysis of 10 additional cases","volume":"26","author":"Bagu\u00e9","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2025.03.021_bb0080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PAS.0b013e3181451b93","article-title":"Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcomalike mural nodules","volume":"32","author":"Provenza","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2025.03.021_bb0085","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.ygyno.2025.03.021_bb0090","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2023.05.059","article-title":"Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma","volume":"174","author":"Rios-Doria","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.021_bb0095","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41379-020-00721-6","article-title":"Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes","volume":"34","author":"Moukarzel","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2025.03.021_bb0100","article-title":"Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer","volume":"131","author":"Sullivan","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2025.03.021_bb0105","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ygyno.2010.02.010","article-title":"Unmasking the complexities of mucinous ovarian carcinoma","volume":"117","author":"Frumovitz","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.021_bb0110","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ygyno.2019.03.256","article-title":"An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC\/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor","volume":"153","author":"Gore","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.021_bb0115","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/AOG.0000000000003579","article-title":"Effects of gastrointestinal-type chemotherapy in women with ovarian mucinous carcinoma","volume":"134","author":"Kurnit","year":"2019","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2025.03.021_bb0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2018.05.008","article-title":"Massively parallel sequencing analysis of mucinous ovarian carcinomas: genomic profiling and differential diagnoses","volume":"150","author":"Mueller","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.021_bb0125","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1038\/s41467-019-11862-x","article-title":"The molecular origin and taxonomy of mucinous ovarian carcinoma","volume":"10","author":"Cheasley","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2025.03.021_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13073-015-0210-y","article-title":"Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors","volume":"7","author":"Ryland","year":"2015","journal-title":"Genome Med."},{"key":"10.1016\/j.ygyno.2025.03.021_bb0135","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa2212419","article-title":"Adagrasib with or without cetuximab in colorectal cancer with mutated KRAS G12C","volume":"388","author":"Yaeger","year":"2023","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ygyno.2025.03.021_bb0140","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.3390\/cancers15082375","article-title":"The therapeutic landscape for KRAS-mutated colorectal cancers","volume":"15","author":"Tria","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ygyno.2025.03.021_bb0145","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1038\/s41467-021-24562-2","article-title":"Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting","volume":"12","author":"Bear","year":"2021","journal-title":"Nat. Commun."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825000903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825000903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:23:10Z","timestamp":1777641790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825825000903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":29,"alternative-id":["S0090825825000903"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.03.021","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anaplastic carcinoma of the ovary: A single-institution experience and molecular analysis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}